505(b)(2): It’s A Different Animal
Camargo
Headlines > Clinical Development
Managing strategic relationships in cancer trials
Related topics: Clinical Development
Speakers
Mr Gareth Macdonald
Senior Editor
Outsourcing-Pharma.com
Mr Lee S Scheible
Sourcing consultant & relationship manager - Oncology
Eli Lilly
The way drug companies work with CROs is evolving, with the emphasis shifting from the client-service provider model to a more strategic, long-term relationship focused approach.
This presentation will discuss the role strategic partnerships can play in trialling cancer drugs with specific examples from current high-profile collaboration.
Points addressed:
- What are the benefits of a strategic partnership approach to cancer drug development?</li>
- Our approach – why this partnering model was chosen?
- Future of partnering in cancer development
Copyright - Unless otherwise stated all contents of this web site are © 2013 - William Reed Business Media SAS - All Rights Reserved - Full details for the use of materials on this site can be found in the Terms & Conditions
All Webinars
  |
State of the marketOn average over half the cost of developing a new cancer drug is associated with... |
 |
Patient recruitment: improving access to patientsRecruiting patients is often, if not always, the most expensive and time consuming part of... |
 |
Managing strategic relationships in cancer trialsThe way drug companies work with CROs is evolving, with the emphasis shifting from the... |
